100 results
Page 3 of 5
8-K
EX-99.1
qsd3htbpv5gxkwc9
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
CORRESP
0lj zffct0v
31 Jan 20
Correspondence with SEC
12:00am
8-K
EX-99.1
d6a0kzzqetdfjb
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
u9lflunh5kwvhnyabfxq
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
CORRESP
vipcox 0q
13 Dec 19
Correspondence with SEC
12:00am
8-K
EX-99.2
6b21182r63uaqj
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
58ua3t4 g45mi
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
1rvo8
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
10y4t76buwnus
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
7b7lar82i11au
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
orro8q e9pab0hk
28 Jun 19
Regulation FD Disclosure
9:01am
8-K
EX-99.1
of14v9lez 9xi
15 Apr 19
Other Events
9:00am
8-K
EX-99.1
aeyjiz8pcv3ja
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am